+ Add Chrome Extension

CNN

News
Feb 26, 2021
2  Likes 0  Comments

About this Deal

Vaccine advisers to the US Food and Drug Administration voted Friday to recommend the agency grant emergency use authorization to Johnson & Johnson's coronavirus vaccine.

The FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted unanimously to recommend EUA of the vaccine in people 18 and older.
If the FDA acts on the recommendation -- and it's expected to do so quickly -- the vaccine will become the third authorized for use in the United States. It will be the first one-shot vaccine, and one that can be stored in regular refrigerators, making it easier to distribute than the Pfizer/BioNTech and Moderna vaccines, which are more delicate and require two doses.
The vaccine, made by Johnson & Johnson's vaccine arm, Janssen, was tested in advanced clinical trials in more than 44,000 people in the US, South Africa and Latin America. Globally, it showed an overall efficacy of 66% in preventing moderate-to-severe disease. In the US, this efficacy was 72% and it was 85% effective in preventing severe disease. No one who got the vaccine died of Covid-19 during the trial.

Read the full article here

🏷 Deal Tags

News CNN FDA Covid-19 vaccine
What's the matter?

💬 Comments

Thanks! Worked! 👍 🙏 🤩 💕 🥳 🔥 😍
👀 Related Deals